Stemming the Global Trade in Falsified and Substandard Medicines
Today, criminals and unscrupulous manufacturers have permeated the global pharmaceutical market, calling into question this basic assumption of clinical practice. Between Nov 2012 and Mar 2013, an injectable drug compounded under unhygienic conditions at the New England Compounding Pharmacy was link...
Gespeichert in:
| Veröffentlicht in: | JAMA : the journal of the American Medical Association 2013-04, Vol.309 (16), p.1693-1694 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1694 |
|---|---|
| container_issue | 16 |
| container_start_page | 1693 |
| container_title | JAMA : the journal of the American Medical Association |
| container_volume | 309 |
| creator | Gostin, Lawrence O Buckley, Gillian J Kelley, Patrick W |
| description | Today, criminals and unscrupulous manufacturers have permeated the global pharmaceutical market, calling into question this basic assumption of clinical practice. Between Nov 2012 and Mar 2013, an injectable drug compounded under unhygienic conditions at the New England Compounding Pharmacy was linked to more than 700 illnesses and 50 deaths. In poor countries, where drug regulatory oversight is weaker, the problem is worse, but blends with the background noise of high mortality and strained health systems. Here, Gostin et al examine the causes of, and solutions to, the problem of falsified and substandard drugs in the US and globally. |
| doi_str_mv | 10.1001/jama.2013.3048 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1346117401</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>1677391</ama_id><sourcerecordid>2969497191</sourcerecordid><originalsourceid>FETCH-LOGICAL-a382t-e5826bff56ebb3a486a5c72716342d39619de26f037460d73c71816e433f3eb93</originalsourceid><addsrcrecordid>eNpdkD1PwzAURS0EoqWwMjCgSCwsCXaeYzsbqKIFqYihZY6c-AVS5aPYycC_x1FLB7zYks-9eu8Qcs1oxChlD1vd6CimDCKgXJ2QKUtAhZCk6pRMKU1VKLniE3Lh3Jb6w0Cek0kMiUwhZVPyuO6xaar2M-i_MFjWXa7rYGO1waBqg4WuXVVWaALdmmA95K73D21N8IamKqoW3SU5Kz2FV4d7Rj4Wz5v5S7h6X77On1ahBhX3ISYqFnlZJgLzHDRXQieFjCUTwGMDqWCpwViUFCQX1EgoJFNMIAcoAfMUZuR-37uz3feArs-ayhVY17rFbnAZAy4Yk9xvOCN3_9BtN9jWT-ephCYp8148Fe2pwnbOWSyzna0abX8yRrPRbTa6zUa32ejWB24PtUPeoDnifzI9cLMHxtyxTEg5fv4CgcV6hg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1350591098</pqid></control><display><type>article</type><title>Stemming the Global Trade in Falsified and Substandard Medicines</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Gostin, Lawrence O ; Buckley, Gillian J ; Kelley, Patrick W</creator><creatorcontrib>Gostin, Lawrence O ; Buckley, Gillian J ; Kelley, Patrick W</creatorcontrib><description>Today, criminals and unscrupulous manufacturers have permeated the global pharmaceutical market, calling into question this basic assumption of clinical practice. Between Nov 2012 and Mar 2013, an injectable drug compounded under unhygienic conditions at the New England Compounding Pharmacy was linked to more than 700 illnesses and 50 deaths. In poor countries, where drug regulatory oversight is weaker, the problem is worse, but blends with the background noise of high mortality and strained health systems. Here, Gostin et al examine the causes of, and solutions to, the problem of falsified and substandard drugs in the US and globally.</description><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.2013.3048</identifier><identifier>PMID: 23579391</identifier><identifier>CODEN: JAMAAP</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Commerce - standards ; Commerce - trends ; Counterfeit Drugs - adverse effects ; Counterfeit Drugs - supply & distribution ; Counterfeiting ; Drug Contamination ; Drug Industry - standards ; Drug Industry - trends ; Drug policy ; Drugs ; Government Regulation ; Humans ; International markets ; Internationality ; Licensure ; Mortality ; Pharmacovigilance ; Product quality ; Quality Control ; Terminology as Topic ; United States ; World Health Organization</subject><ispartof>JAMA : the journal of the American Medical Association, 2013-04, Vol.309 (16), p.1693-1694</ispartof><rights>Copyright American Medical Association Apr 24, 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a382t-e5826bff56ebb3a486a5c72716342d39619de26f037460d73c71816e433f3eb93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/jama.2013.3048$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2013.3048$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,314,780,784,3340,27924,27925,76489,76492</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23579391$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gostin, Lawrence O</creatorcontrib><creatorcontrib>Buckley, Gillian J</creatorcontrib><creatorcontrib>Kelley, Patrick W</creatorcontrib><title>Stemming the Global Trade in Falsified and Substandard Medicines</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><description>Today, criminals and unscrupulous manufacturers have permeated the global pharmaceutical market, calling into question this basic assumption of clinical practice. Between Nov 2012 and Mar 2013, an injectable drug compounded under unhygienic conditions at the New England Compounding Pharmacy was linked to more than 700 illnesses and 50 deaths. In poor countries, where drug regulatory oversight is weaker, the problem is worse, but blends with the background noise of high mortality and strained health systems. Here, Gostin et al examine the causes of, and solutions to, the problem of falsified and substandard drugs in the US and globally.</description><subject>Commerce - standards</subject><subject>Commerce - trends</subject><subject>Counterfeit Drugs - adverse effects</subject><subject>Counterfeit Drugs - supply & distribution</subject><subject>Counterfeiting</subject><subject>Drug Contamination</subject><subject>Drug Industry - standards</subject><subject>Drug Industry - trends</subject><subject>Drug policy</subject><subject>Drugs</subject><subject>Government Regulation</subject><subject>Humans</subject><subject>International markets</subject><subject>Internationality</subject><subject>Licensure</subject><subject>Mortality</subject><subject>Pharmacovigilance</subject><subject>Product quality</subject><subject>Quality Control</subject><subject>Terminology as Topic</subject><subject>United States</subject><subject>World Health Organization</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkD1PwzAURS0EoqWwMjCgSCwsCXaeYzsbqKIFqYihZY6c-AVS5aPYycC_x1FLB7zYks-9eu8Qcs1oxChlD1vd6CimDCKgXJ2QKUtAhZCk6pRMKU1VKLniE3Lh3Jb6w0Cek0kMiUwhZVPyuO6xaar2M-i_MFjWXa7rYGO1waBqg4WuXVVWaALdmmA95K73D21N8IamKqoW3SU5Kz2FV4d7Rj4Wz5v5S7h6X77On1ahBhX3ISYqFnlZJgLzHDRXQieFjCUTwGMDqWCpwViUFCQX1EgoJFNMIAcoAfMUZuR-37uz3feArs-ayhVY17rFbnAZAy4Yk9xvOCN3_9BtN9jWT-ephCYp8148Fe2pwnbOWSyzna0abX8yRrPRbTa6zUa32ejWB24PtUPeoDnifzI9cLMHxtyxTEg5fv4CgcV6hg</recordid><startdate>20130424</startdate><enddate>20130424</enddate><creator>Gostin, Lawrence O</creator><creator>Buckley, Gillian J</creator><creator>Kelley, Patrick W</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20130424</creationdate><title>Stemming the Global Trade in Falsified and Substandard Medicines</title><author>Gostin, Lawrence O ; Buckley, Gillian J ; Kelley, Patrick W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a382t-e5826bff56ebb3a486a5c72716342d39619de26f037460d73c71816e433f3eb93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Commerce - standards</topic><topic>Commerce - trends</topic><topic>Counterfeit Drugs - adverse effects</topic><topic>Counterfeit Drugs - supply & distribution</topic><topic>Counterfeiting</topic><topic>Drug Contamination</topic><topic>Drug Industry - standards</topic><topic>Drug Industry - trends</topic><topic>Drug policy</topic><topic>Drugs</topic><topic>Government Regulation</topic><topic>Humans</topic><topic>International markets</topic><topic>Internationality</topic><topic>Licensure</topic><topic>Mortality</topic><topic>Pharmacovigilance</topic><topic>Product quality</topic><topic>Quality Control</topic><topic>Terminology as Topic</topic><topic>United States</topic><topic>World Health Organization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gostin, Lawrence O</creatorcontrib><creatorcontrib>Buckley, Gillian J</creatorcontrib><creatorcontrib>Kelley, Patrick W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gostin, Lawrence O</au><au>Buckley, Gillian J</au><au>Kelley, Patrick W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stemming the Global Trade in Falsified and Substandard Medicines</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>2013-04-24</date><risdate>2013</risdate><volume>309</volume><issue>16</issue><spage>1693</spage><epage>1694</epage><pages>1693-1694</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><coden>JAMAAP</coden><abstract>Today, criminals and unscrupulous manufacturers have permeated the global pharmaceutical market, calling into question this basic assumption of clinical practice. Between Nov 2012 and Mar 2013, an injectable drug compounded under unhygienic conditions at the New England Compounding Pharmacy was linked to more than 700 illnesses and 50 deaths. In poor countries, where drug regulatory oversight is weaker, the problem is worse, but blends with the background noise of high mortality and strained health systems. Here, Gostin et al examine the causes of, and solutions to, the problem of falsified and substandard drugs in the US and globally.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>23579391</pmid><doi>10.1001/jama.2013.3048</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0098-7484 |
| ispartof | JAMA : the journal of the American Medical Association, 2013-04, Vol.309 (16), p.1693-1694 |
| issn | 0098-7484 1538-3598 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1346117401 |
| source | MEDLINE; American Medical Association Journals |
| subjects | Commerce - standards Commerce - trends Counterfeit Drugs - adverse effects Counterfeit Drugs - supply & distribution Counterfeiting Drug Contamination Drug Industry - standards Drug Industry - trends Drug policy Drugs Government Regulation Humans International markets Internationality Licensure Mortality Pharmacovigilance Product quality Quality Control Terminology as Topic United States World Health Organization |
| title | Stemming the Global Trade in Falsified and Substandard Medicines |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T18%3A19%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stemming%20the%20Global%20Trade%20in%20Falsified%20and%20Substandard%20Medicines&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Gostin,%20Lawrence%20O&rft.date=2013-04-24&rft.volume=309&rft.issue=16&rft.spage=1693&rft.epage=1694&rft.pages=1693-1694&rft.issn=0098-7484&rft.eissn=1538-3598&rft.coden=JAMAAP&rft_id=info:doi/10.1001/jama.2013.3048&rft_dat=%3Cproquest_cross%3E2969497191%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1350591098&rft_id=info:pmid/23579391&rft_ama_id=1677391&rfr_iscdi=true |